Details of the Drug

General Information of Drug (ID: DMJAXTY)

Drug Name
PF-06650833
Indication
Disease Entry ICD 11 Status REF
Lupus 4A40 Phase 1 [1]
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C18H20FN3O4
Canonical SMILES
CCC1C(NC(=O)C1F)COC2=NC=CC3=CC(=C(C=C32)OC)C(=O)N
InChI
InChI=1S/C18H20FN3O4/c1-3-10-13(22-17(24)15(10)19)8-26-18-11-7-14(25-2)12(16(20)23)6-9(11)4-5-21-18/h4-7,10,13,15H,3,8H2,1-2H3,(H2,20,23)(H,22,24)/t10-,13+,15-/m0/s1
InChIKey
JKDGKIBAOAFRPJ-ZBINZKHDSA-N
Cross-matching ID
PubChem CID
118414016
ChEBI ID
CHEMBL4081711
CAS Number
1817626-54-2
UNII
S3F315JJXI
DrugBank ID
DB15143
TTD ID
D07NUL
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug

References

1 ClinicalTrials.gov (NCT02224651) Study to Evaluate Safety and Tolerability of Single Ascending Doses of Multiple Formulations of PF-06650833 in Healthy Subjects Under Fasted and Fed Conditions. U.S. National Institutes of Health.